Thyroid Nodule With a Suspicious Lymph Node: Sequencing the Operation
A 45-year-old woman has a 3.8 cm right thyroid nodule. Ultrasound shows a solid, hypoechoic nodule with microcalcifications and irregular margins (TI-RADS 5), plus a 1.4 cm right level III lymph node with loss of fatty hilum and microcalcifications. FNA of the nodule is Bethesda VI (papillary thyroid carcinoma); FNA of the node is positive for metastatic papillary carcinoma. She is otherwise healthy, has a normal voice, and has no prior neck surgery. Her calcium and PTH are normal. She asks whether she can have 'just the lump removed' and whether she will need radioactive iodine.
1. What operation do you recommend and why, and how do you counsel her about the extent of surgery?
Read the worked answer
Recommend total thyroidectomy with central compartment (level VI) dissection and a modified radical neck dissection of the involved lateral compartment (levels II–V or a selective dissection).
Reasoning:
- Lateral neck metastasis is confirmed, so a therapeutic lateral neck dissection is indicated; observation is not appropriate for biopsy-proven lateral disease.
- Total thyroidectomy is favored over lobectomy because: (1) the tumor is >4 cm and/or has nodal metastasis, (2) total thyroidectomy facilitates radioactive iodine (RAI) if indicated and thyroglobulin surveillance, and (3) it addresses bilateral disease risk.
- Central neck dissection is recommended for clinically node-positive lateral disease because occult central metastases are common and reoperation in the central compartment carries higher recurrent laryngeal nerve and parathyroid risk.
- Counsel that lobectomy alone is inadequate here; she needs a total thyroidectomy plus neck dissection, and that the decision about RAI will be made after final pathology and risk stratification.
- Discuss risks: recurrent laryngeal nerve injury (voice change), hypoparathyroidism (transient vs permanent hypocalcemia), hematoma, and scar.
2. Final pathology shows a 4.2 cm papillary carcinoma with 3 positive level III nodes and no extranodal extension. How do you risk-stratify her and decide on radioactive iodine?
Read the worked answer
Risk stratification (ATA):
- Tumor >4 cm and lymph node metastases place her in the intermediate-risk category (assuming no gross extrathyroidal extension and no extranodal extension).
- Intermediate risk generally supports RAI ablation after total thyroidectomy, but the decision is individualized.
Decision-making:
- RAI is reasonable to reduce recurrence risk and to facilitate whole-body scanning and thyroglobulin surveillance; it is not clearly associated with improved survival in intermediate-risk disease.
- Prepare for RAI with a low-iodine diet and TSH stimulation (withdrawal or recombinant TSH); give levothyroxine after.
- Surveillance: neck ultrasound and thyroglobulin/anti-thyroglobulin antibodies at 6–12 months; dynamic risk stratification at 1 year - if excellent response (undetectable Tg, no structural disease), de-escalate follow-up.
- Counsel that RAI carries small risks (salivary gland dysfunction, secondary malignancy) and that the benefit is mainly recurrence reduction.